{"nodes": [{"id": "0", "name": "2ThemartComInc_19990826_10-12G_EX-10.10_6700288_EX-10.10_Co-Branding Agreement_ Agency Agreement.txt", "description": "CO-BRANDING AND ADVERTISING AGREEMENT\n\nTHIS CO-BRANDING AND ADVERTISING AGREEMENT (the \"Agreement\") is made as of June 21, 1999 (the \"Effective Date\") by and between I-ESCROW, INC., with its principal", "group": 5, "connections": 1}, {"id": "1", "name": "ABILITYINC_06_15_2020-EX-4.25-SERVICES AGREEMENT.txt", "description": "EXHIBIT 4.25 INFORMATION IN THIS EXHIBIT IDENTIFIED BY [ * * * ] IS CONFIDENTIAL AND HAS BEEN EXCLUDED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRAN", "group": 5, "connections": 2}, {"id": "2", "name": "ACCELERATEDTECHNOLOGIESHOLDINGCORP_04_24_2003-EX-10.13-JOINT VENTURE AGREEMENT.txt", "description": "EXHIBIT 10.13\n\n                             JOINT VENTURE AGREEMENT\n\nCollectible Concepts Group, Inc. (\"CCGI\") and Pivotal Self Service Tech, Inc. (\"PVSS\"), (the \"Parties\" or \"Joint Venturers\" if refe", "group": 5, "connections": 0}, {"id": "3", "name": "ACCURAYINC_09_01_2010-EX-10.31-DISTRIBUTOR AGREEMENT.txt", "description": "Exhibit 10.31    PURSUANT TO 17 C.F.R. \u00a7 240.24B-2, CONFIDENTIAL INFORMATION (INDICATED BY {*****}) HAS BEEN OMITTED FROM THIS  DOCUMENT AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE ", "group": 5, "connections": 4}, {"id": "4", "name": "ADAMSGOLFINC_03_21_2005-EX-10.17-ENDORSEMENT AGREEMENT.txt", "description": "REDACTED COPY\n\nCONFIDENTIAL TREATMENT REQUESTED\n\nCONFIDENTIAL PORTIONS OF THIS\n\nDOCUMENT HAVE BEEN REDACTED\n\nAND HAVE BEEN SEPARATELY\n\nFILED WITH THE COMMISSION\n\n  1\n\n\n\n\n\nENDORSEMENT AGREEMENT\n\nThis A", "group": 5, "connections": 2}, {"id": "5", "name": "ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.txt", "description": "Exhibit 10.11   ***Certain portions of this exhibit have been omitted based on a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended. The om", "group": 5, "connections": 4}, {"id": "6", "name": "ADIANUTRITION,INC_04_01_2005-EX-10.D2-RESELLER AGREEMENT.txt", "description": "Exhibit 10d-2\n\n                               RESELLER AGREEMENT\n\n                                 BY AND BETWEEN\n\n                                PIVX CORPORATION\n\n                                   ", "group": 5, "connections": 1}, {"id": "7", "name": "ADMA BioManufacturing, LLC -  Amendment #3 to Manufacturing Agreement .txt", "description": "Confidential treatment has been requested with respect to portions of this agreement as indicated by \"[***]\" and such confidential portions have been deleted and filed separately with the Securities a", "group": 5, "connections": 4}, {"id": "8", "name": "ADUROBIOTECH,INC_06_02_2020-EX-10.7-CONSULTING AGREEMENT(1).txt", "description": "Exhibit 10.7\n\nCONSULTING AGREEMENT\n\nAduro Biotech, Inc., with a place of business at 740 Heinz Avenue, Berkeley, CA 94710 (\"Aduro\") and IREYA B.V having an address at Staalwijkstraat 16, 2313 XR Leide", "group": 5, "connections": 2}, {"id": "9", "name": "ADUROBIOTECH,INC_06_02_2020-EX-10.7-CONSULTING AGREEMENT.txt", "description": "Exhibit 10.7\n\nCONSULTING AGREEMENT\n\nAduro Biotech, Inc., with a place of business at 740 Heinz Avenue, Berkeley, CA 94710 (\"Aduro\") and IREYA B.V having an address at Staalwijkstraat 16, 2313 XR Leide", "group": 5, "connections": 2}, {"id": "10", "name": "AFSALABANCORPINC_08_01_1996-EX-1.1-AGENCY AGREEMENT.txt", "description": "Exhibit 1.1\n\n                                1,265,000 Shares                    (subject to increase up to 1,454,750 shares                       in the event of an oversubscription)\n\n               ", "group": 5, "connections": 1}, {"id": "11", "name": "AgapeAtpCorp_20191202_10-KA_EX-10.1_11911128_EX-10.1_Supply Agreement.txt", "description": "ODM - SUPPLY AGREEMENT BETWEEN: ORGANIC PREPARATIONS INC. 2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu \"the Manufacturer\" -- AND -- AGAPE ATP INTERNATIONAL HOLDING LIMITED Unit 05, 4F", "group": 5, "connections": 0}, {"id": "12", "name": "AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement.txt", "description": "Exhibit 10.3\n\n[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive har", "group": 5, "connections": 0}, {"id": "13", "name": "AIRSPANNETWORKSINC_04_11_2000-EX-10.5-Distributor Agreement.txt", "description": "Exhibit 10.5\n\nNote: Portions of this exhibit indicated by\"[*]\" are subject to a confidential treatment request, and have been omitted from this exhibit. Complete, unredacted copies of this exhibit hav", "group": 5, "connections": 3}, {"id": "14", "name": "AIRTECHINTERNATIONALGROUPINC_05_08_2000-EX-10.4-FRANCHISE AGREEMENT.txt", "description": "[LOGO]\n\n                                    EXHIBIT C\n\n                                    AIRSOPURE                                FRANCHISE AGREEMENT\n\nTHIS AGREEMENT is entered into on this ____ day", "group": 5, "connections": 0}, {"id": "15", "name": "ALAMOGORDOFINANCIALCORP_12_16_1999-EX-1-AGENCY AGREEMENT.txt", "description": "ALAMOGORDO FINANCIAL CORPORATION                                 1,101,643 Shares\n\n                                  COMMON STOCK                            (Par Value $.0l Per Share)\n\n               ", "group": 5, "connections": 0}, {"id": "16", "name": "ALCOSTORESINC_12_14_2005-EX-10.26-AGENCY AGREEMENT.txt", "description": "Exhibit 10.26\n\nAGENCY AGREEMENT\n\nTHIS AGENCY AGREEMENT, dated November 9, 2005 (\"Agreement\"), between General Electric Capital Corporation, a Delaware corporation (together with its successors and ass", "group": 5, "connections": 0}, {"id": "17", "name": "ALLIANCEBANCORPINCOFPENNSYLVANIA_10_18_2006-EX-1.2-AGENCY AGREEMENT.txt", "description": "Exhibit 1.2\n\nUp to 2,445,223 Shares\n\n(subject to increase to up to 2,812,006 shares in the event of an increase in the pro forma market value of the Company's Common Stock)\n\nAlliance Bancorp, Inc. of ", "group": 5, "connections": 0}, {"id": "18", "name": "AlliedEsportsEntertainmentInc_20190815_8-K_EX-10.19_11788293_EX-10.19_Content License Agreement.txt", "description": "Exhibit 10.19 JOINT CONTENT LICENSE AGREEMENT This JOINT CONTENT LICENSE AGREEMENT (the \"Agreement\"), dated February 1, 2018 (the \"Effective Date\"), is made by and between WPT Enterprises, Inc., a Del", "group": 5, "connections": 0}, {"id": "19", "name": "AlliedEsportsEntertainmentInc_20190815_8-K_EX-10.34_11788308_EX-10.34_Sponsorship Agreement.txt", "description": "Exhibit 10.34 EVENT SPONSORSHIP AGREEMENT This Event Sponsorship Agreement (\"Agreement\") is made and effective as of February 1, 2019 (the \"Effective Date\"), by and between Newegg Inc. (\"Newegg\"), a D", "group": 5, "connections": 0}, {"id": "20", "name": "ALLISONTRANSMISSIONHOLDINGSINC_12_15_2014-EX-99.1-COOPERATION AGREEMENT.txt", "description": "Exhibit 99.1\n\nCOOPERATION AGREEMENT\n\nThis Cooperation Agreement (this \"Agreement\") dated December 12, 2014, is by and among the persons and entities listed on Schedule A (collectively, the \"ValueAct G", "group": 5, "connections": 1}, {"id": "21", "name": "AMBASSADOREYEWEARGROUPINC_11_17_1997-EX-10.28-ENDORSEMENT AGREEMENT.txt", "description": "Exhibit 10.28\n\n                              ENDORSEMENT AGREEMENT\n\n            This Endorsement Agreement (\"Agreement\") is made and entered into as of August 24, 1995, by and among the following part", "group": 5, "connections": 0}, {"id": "22", "name": "AMERICANPHYSICIANSCAPITALINC_03_31_2003-EX-10.26-AGENCY AGREEMENT.txt", "description": "EXHIBIT 10.26                                       MICOA                                 AGENCY AGREEMENT\n\n         Mutual Insurance Corporation of America, a Michigan insurance corporation (MICOA) a", "group": 5, "connections": 0}, {"id": "23", "name": "AMERICASSHOPPINGMALLINC_12_10_1999-EX-10.2-SITE DEVELOPMENT AND HOSTING AGREEMENT.txt", "description": "EXHIBIT 10.2\n\n                    SITE DEVELOPMENT AND HOSTING AGREEMENT\n\n                  This SITE DEVELOPMENT AND HOSTING AGREEMENT (the \"Agreement\") dated as of August 9, 1999 is made between Han", "group": 5, "connections": 0}, {"id": "24", "name": "ANIXABIOSCIENCESINC_06_09_2020-EX-10.1-COLLABORATION AGREEMENT.txt", "description": "Exhibit 10.1\n\nRedactions with respect to certain portions hereof denoted with \"***\"\n\nCOLLABORATION AGREEMENT\n\nThis Collaboration Agreement (the \"Agreement\") is made as of April 14th, 2020 (the \"Effect", "group": 5, "connections": 1}, {"id": "25", "name": "Antares Pharma, Inc. - Manufacturing Agreement.txt", "description": "Exhibit 10.3\n\n[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSI", "group": 5, "connections": 6}, {"id": "26", "name": "Apollo Endosurgery - Manufacturing and Supply Agreement.txt", "description": "Exhibit 10.19 CONFIDENTIAL TREATMENT REQUESTED Certain portions of this document have been omitted pursuant to a request for Confidential Treatment and, where applicable, have been marked with \"[***]\"", "group": 5, "connections": 3}, {"id": "27", "name": "ArcaUsTreasuryFund_20200207_N-2_EX-99.K5_11971930_EX-99.K5_Development Agreement.txt", "description": "Exhibit 99(k)(5) FORM OF BLOCKCHAIN ADMINISTRATION AND DEVELOPMENT AGREEMENT BETWEEN ARCA U.S. TREASURY FUND AND ARCA CAPITAL MANAGEMENT, LLC This Agreement (\"Agreement\") is made as of [___], 2020 by ", "group": 5, "connections": 0}, {"id": "28", "name": "ArcGroupInc_20171211_8-K_EX-10.1_10976103_EX-10.1_Sponsorship Agreement.txt", "description": "Exhibit 10.1   JACKSONVILLE JAGUARS SPONSORSHIP AGREEMENT   This Sponsorship Agreement (this \"Agreement\") is entered into as of November 27, 2017 (the \"Execution Date\") by and between Jacksonville Jag", "group": 5, "connections": 0}, {"id": "29", "name": "ArconicRolledProductsCorp_20191217_10-12B_EX-2.7_11923804_EX-2.7_Trademark License Agreement.txt", "description": "Exhibit 2.7 FORM OF TRADEMARK LICENSE AGREEMENT THIS TRADEMARK LICENSE AGREEMENT (this \"Agreement\"), made and entered into as of the [ ] day of [ ], 2020 (the \"Effective Date\"), by and between ARCONIC", "group": 5, "connections": 0}, {"id": "30", "name": "2ThemartComInc_19990826_10-12G_EX-10.10_6700288_EX-10.10_Co-Branding_Agreement__Agency_Agreement.txt", "description": "CO-BRANDING AND ADVERTISING AGREEMENT\n\nTHIS CO-BRANDING AND ADVERTISING AGREEMENT (the \"Agreement\") is made as of June 21, 1999 (the \"Effective Date\") by and between I-ESCROW, INC., with its principal", "group": 6, "connections": 1}, {"id": "31", "name": "ACCURAYINC_09_01_2010-EX-10.31-DISTRIBUTOR_AGREEMENT.txt", "description": "Exhibit 10.31    PURSUANT TO 17 C.F.R. \u00a7 240.24B-2, CONFIDENTIAL INFORMATION (INDICATED BY {*****}) HAS BEEN OMITTED FROM THIS  DOCUMENT AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE ", "group": 6, "connections": 4}, {"id": "32", "name": "ADAMSGOLFINC_03_21_2005-EX-10.17-ENDORSEMENT_AGREEMENT.txt", "description": "REDACTED COPY\n\nCONFIDENTIAL TREATMENT REQUESTED\n\nCONFIDENTIAL PORTIONS OF THIS\n\nDOCUMENT HAVE BEEN REDACTED\n\nAND HAVE BEEN SEPARATELY\n\nFILED WITH THE COMMISSION\n\n  1\n\n\n\n\n\nENDORSEMENT AGREEMENT\n\nThis A", "group": 6, "connections": 2}, {"id": "33", "name": "ADIANUTRITION,INC_04_01_2005-EX-10.D2-RESELLER_AGREEMENT.txt", "description": "Exhibit 10d-2\n\n                               RESELLER AGREEMENT\n\n                                 BY AND BETWEEN\n\n                                PIVX CORPORATION\n\n                                   ", "group": 6, "connections": 1}, {"id": "34", "name": "ADUROBIOTECH,INC_06_02_2020-EX-10.7-CONSULTING_AGREEMENT(1).txt", "description": "Exhibit 10.7\n\nCONSULTING AGREEMENT\n\nAduro Biotech, Inc., with a place of business at 740 Heinz Avenue, Berkeley, CA 94710 (\"Aduro\") and IREYA B.V having an address at Staalwijkstraat 16, 2313 XR Leide", "group": 6, "connections": 2}, {"id": "35", "name": "AFSALABANCORPINC_08_01_1996-EX-1.1-AGENCY_AGREEMENT.txt", "description": "Exhibit 1.1\n\n                                1,265,000 Shares                    (subject to increase up to 1,454,750 shares                       in the event of an oversubscription)\n\n               ", "group": 6, "connections": 1}, {"id": "36", "name": "BNLFINANCIALCORP_03_30_2007-EX-10.8-OUTSOURCING_AGREEMENT.txt", "description": "VIRTUAL ITEM PROCESSING SYSTEMS, INC. 2525 Northwest Expressway, #105   Oklahoma City, Oklahoma 73112\n\nOUTSOURCING AGREEMENT   BETWEEN   VIRTUAL ITEM PROCESSING SYSTEMS, INC.   And   BROKERS NATIONAL ", "group": 6, "connections": 0}], "links": [{"source": "0", "target": "30", "value": 0.9999998807907104}, {"source": "1", "target": "13", "value": 0.7707107067108154}, {"source": "1", "target": "25", "value": 0.7179552316665649}, {"source": "3", "target": "5", "value": 0.8023731112480164}, {"source": "3", "target": "7", "value": 0.7071933746337891}, {"source": "3", "target": "25", "value": 0.8274211883544922}, {"source": "3", "target": "31", "value": 1.0}, {"source": "4", "target": "7", "value": 0.7126160264015198}, {"source": "4", "target": "32", "value": 1.0}, {"source": "5", "target": "25", "value": 0.8144897222518921}, {"source": "5", "target": "26", "value": 0.7337524890899658}, {"source": "5", "target": "31", "value": 0.8023731112480164}, {"source": "6", "target": "33", "value": 1.000000238418579}, {"source": "7", "target": "31", "value": 0.7071933746337891}, {"source": "7", "target": "32", "value": 0.7126160264015198}, {"source": "8", "target": "9", "value": 1.0}, {"source": "8", "target": "34", "value": 1.0}, {"source": "9", "target": "34", "value": 1.0}, {"source": "10", "target": "35", "value": 1.0}, {"source": "13", "target": "25", "value": 0.7954851388931274}, {"source": "13", "target": "26", "value": 0.852935791015625}, {"source": "20", "target": "24", "value": 0.7294824123382568}, {"source": "25", "target": "26", "value": 0.8275508284568787}, {"source": "25", "target": "31", "value": 0.8274211883544922}], "metadata": {"total_nodes": 37, "total_links": 24, "field_groups": {"file": 5, "new": 6}, "field_group_counts": {"5": 30, "6": 7}}}